{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:37:05Z","timestamp":1694626625219},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T00:00:00Z","timestamp":1155168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T00:00:00Z","timestamp":1155168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2006,11,1]]},"DOI":"10.1038\/sj.jhh.1002070","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T11:07:54Z","timestamp":1155812874000},"page":"829-832","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does eplerenone have a future in the management of hypertension in Europe?"],"prefix":"10.1038","volume":"20","author":[{"given":"P","family":"Gosse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Macfadyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,10]]},"reference":[{"key":"BF1002070_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mce.2003.10.008","volume":"217","author":"J Menard","year":"2004","unstructured":"Menard J . The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Mol Cell Endocrinol 2004; 217: 45\u201352.","journal-title":"Mol Cell Endocrinol"},{"key":"BF1002070_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1210\/endo-97-1-52","volume":"97","author":"P Corvol","year":"1975","unstructured":"Corvol P, Michaud A, Menard J, Freifeld M, Mahoudeau J . Antiandrogenic effect of spironolactone: mechanisms of action. Endocrinology 1975; 97: 52\u201358.","journal-title":"Endocrinology"},{"key":"BF1002070_CR3","first-page":"64","volume-title":"External Activity of Aldosterone and its Antagonists","author":"A Froment","year":"1971","unstructured":"Froment A, Milon H . Etude en double aveugle de l'adjonction de spironolactone au traitement antihypertenseur thiazidique. La fr\u00e9quence de la gyn\u00e9comastie aur cours des tratements prolong\u00e9s. In: External Activity of Aldosterone and its Antagonists. Excerpta Medica: Paris, 1971, pp 64\u201369."},{"key":"BF1002070_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"Jeunemaitre X, Chatellier G, Kreft-Jais C, Charru A, DeVries C, Plouin PF et al. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 1987; 60: 820\u2013825.","journal-title":"Am J Cardiol"},{"key":"BF1002070_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","volume":"19","author":"PO Lim","year":"2001","unstructured":"Lim PO, Young WF, MacDonald TM . A review of the medical treatment of primary aldosteronism. J Hypertens 2001; 19: 353\u2013361.","journal-title":"J Hypertens"},{"key":"BF1002070_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA . Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003; 16: 925\u2013930.","journal-title":"Am J Hypertens"},{"key":"BF1002070_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","volume":"150","author":"MH Weinberger","year":"2005","unstructured":"Weinberger MH, White WB, Ruilope LM, MacDonald TM, Davidson RC, Roniker B et al. Effects of eplerenone versus losartan in patients with low-renin hypertension. Am Heart J 2005; 150: 426\u2013433.","journal-title":"Am Heart J"},{"key":"BF1002070_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309\u20131321.","journal-title":"N Engl J Med"},{"key":"BF1002070_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH, Roniker B, Krause SL, Weiss RJ . Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 2002; 15: 709\u2013716.","journal-title":"Am J Hypertens"},{"key":"BF1002070_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","volume":"41","author":"WB White","year":"2003","unstructured":"White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J et al. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 2003; 41: 1021\u20131026.","journal-title":"Hypertension"},{"key":"BF1002070_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","volume":"41","author":"JM Flack","year":"2003","unstructured":"Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH et al. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol 2003; 41: 1148\u20131155.","journal-title":"J Am Coll Cardiol"},{"key":"BF1002070_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","volume":"93","author":"GH Williams","year":"2004","unstructured":"Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol 2004; 93: 990\u2013996.","journal-title":"Am J Cardiol"},{"key":"BF1002070_CR13","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","volume":"25","author":"ED Burgess","year":"2003","unstructured":"Burgess ED, Lacourciere Y, Ruilope-Urioste LM, Oparil S, Kleiman JH, Krause S et al. Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Clin Ther 2003; 25: 2388\u20132404.","journal-title":"Clin Ther"},{"key":"BF1002070_CR14","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","volume":"108","author":"B Pitt","year":"2003","unstructured":"Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B et al. Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 2003; 108: 1831\u20131838.","journal-title":"Circulation"},{"key":"BF1002070_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1177\/0091270003258189","volume":"43","author":"LM Prisant","year":"2003","unstructured":"Prisant LM, Krum H, Roniker B, Krause SL, Fakouhi K, He W . Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy? J Clin Pharmacol 2003; 43: 1203\u20131210.","journal-title":"J Clin Pharmacol"},{"key":"BF1002070_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709\u2013717.","journal-title":"N Engl J Med"},{"issue":"9","key":"BF1002070_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.jhh.1002058","volume":"20","author":"S Jessani","year":"2006","unstructured":"Jessani S, Watson T, Cappuccio FP, Lip GY . Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines. J Hum Hypertens 2006 (doi:10.1038\/sj.jhh.1002058).","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"BF1002070_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","volume":"18","author":"B Williams","year":"2004","unstructured":"Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al., British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18 (3): 139\u2013185.","journal-title":"J Hum Hypertens"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1002070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002070","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1002070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:38:22Z","timestamp":1647549502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,10]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"alternative-id":["BF1002070"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1002070","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,10]]},"assertion":[{"value":"10 August 2006","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}